Full Text View
Tabular View
No Study Results Posted
Related Studies
Improving Hepatitis C Treatment in Injection Drug Users
This study is ongoing, but not recruiting participants.
Study NCT00148031   Information provided by National Institute on Drug Abuse (NIDA)
First Received: September 2, 2005   Last Updated: July 10, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hepatitis C
Liver Diseases
Drug Abuse
Alcoholism
Additional conditions recognized in this trial
Hepatitis
Substance-Related Disorders
More general conditions related to this trial
Alcohol-Related Disorders
Digestive System Diseases
Disorders of Environmental Origin
Flaviviridae Infections
Hepatitis, Viral, Human
Mental Disorders
RNA Virus Infections
Virus Diseases
Interventions listed in this trial
Pegylated Interferon and Ribavirin
Psychosocial
Additional drug interventions recognized in this trial
Interferons
Ribavirin
More general drug interventions related to this trial
Anti-Infective Agents
Antimetabolites
Antineoplastic Agents
Antiviral Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
National Institute on Drug Abuse (NIDA)
State University of New York - Upstate Medical University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services